Natalia Mühlemann

Vice President, Clinical Development

Natalia Mühlemann brings over 20 years of experience in general management, clinical development, and business development in the life sciences industry to her role at Cytel.

Prior to joining Cytel in 2020, Natalia served as Global Category Head, Acute Care – Oncology – Devices at Nestle Health Sciences. She acts as an Expert Jury member for the European Commission’s Innovation Council.

Natalia holds an MD and an MBA (IMD) and professional certifications in statistics and data science. She continues to expand her education, focusing on AI/ML and CME.

Natalia Mühlemann

Related Articles

The Role of External Data in Oncology Drug Development
Blog
August 1, 2024
The Role of External Data in Oncology Drug Development
Read More
Optimizing Early Clinical Development Strategy
Blog
January 10, 2024
Optimizing Early Clinical Development Strategy
Read More
Quantitative Strategies for Rare Disease Clinical Trials
Blog
March 11, 2024
Quantitative Strategies for Rare Disease Clinical Trials
Read More
Late-Stage Clinical Development Strategy: Trade-Offs and Decision-Making in the Confirmatory Setting
Blog
January 17, 2024
Late-Stage Clinical Development Strategy: Trade-Offs and Decision-Making in the Confirmatory Setting
Read More